We have located links that may give you full text access.
Journal Article
Review
Laser therapy of giant congenital melanocytic nevi.
Giant congenital melanocytic nevi (GCMN) are rare disfiguring potentially malignant lesions present at birth. The approach of these patients is based on two main considerations: attempt to minimize the risk of malignancy, and obtain an acceptable cosmetic result. Sometimes they are too large to be removed by multiple surgical excision or by use of osmotic expander. The objective of treatment of giant congenital nevi is to obtain ablation without side effects or after-effects from aesthetics. But for the moment such treatment doesn't exist. The aim of this review was to access treatment of GCMN with lasers as an alternative to surgery. Lasers should only be regarded as a treatment option for GCMN that cannot be surgically excised. For the moment laser therapy of GCMN should be restricted to well controlled studies or to individual patients in whom surgical procedures are not possible or would result in unacceptable scarring. Today ultrashort high energy pulsed CO2 laser and the normal mode ruby laser are the two lasers available. But the results are too unforeseeable, and painful with these two lasers. The combined use of normal mode and Q-switched ruby lasers or ultrashort high energy pulsed CO2 laser and Q-switched ruby or Nd:YAG lasers can give us a solution. In the future perhaps new Q-switched laser could give us a better way of treatment, with less pain, and no scars. We need an improvement of the technology in this field and hopefully the picosecond systems will be available in the future.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app